Chugai Pharmaceutical Co., Ltd. (CHGCF)
59.73
+0.06
(+0.10%)
USD |
OTCM |
Feb 13, 16:00
Chugai Pharmaceutical EPS Diluted (Quarterly) : 0.5064 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nxera Pharma Co., Ltd. | -0.5548 |
| PeptiDream Inc. | -0.0575 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.0331 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 833.45M |
| Revenue (Quarterly) | 2.248B |
| Total Expenses (Quarterly) | 1.414B |
| Enterprise Value | 92.04B |
| Gross Profit Margin (Quarterly) | 74.72% |
| Profit Margin (Quarterly) | 37.08% |
| Earnings Yield | 2.95% |
| Operating Earnings Yield | 4.27% |